Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Kraig D. Moore, MD

 LICENSE # 0101246079
  Jaxsenscream312@gmail.com

 Issue Date: 7/9/2009
Expiration Date: 1/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 1/16/2022
None Reported
Academic Appointments - Non-US
Last Updated 1/16/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 1/16/2022
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.
Journal of Clinical Oncology
Volume: 27(5):
Date: 12 2008
Journal of Clinical Oncology

A phase I trial of enzastaurin in patients with recurrent gliomas.
Clincal Cancer Research
Volume: 15(10)
Date: 05 2009
Clinical cancer research